Mangoceuticals (MGRX) EBIAT (2023 - 2025)
Historic EBIAT for Mangoceuticals (MGRX) over the last 3 years, with Q3 2025 value amounting to -$7.6 million.
- Mangoceuticals' EBIAT fell 28099.71% to -$7.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$19.8 million, marking a year-over-year decrease of 11253.74%. This contributed to the annual value of -$8.7 million for FY2024, which is 548.38% up from last year.
- Latest data reveals that Mangoceuticals reported EBIAT of -$7.6 million as of Q3 2025, which was down 28099.71% from -$5.4 million recorded in Q2 2025.
- In the past 5 years, Mangoceuticals' EBIAT ranged from a high of -$1.8 million in Q3 2023 and a low of -$7.6 million during Q3 2025
- For the 3-year period, Mangoceuticals' EBIAT averaged around -$3.3 million, with its median value being -$2.4 million (2024).
- In the last 5 years, Mangoceuticals' EBIAT soared by 2412.15% in 2024 and then plummeted by 28099.71% in 2025.
- Over the past 3 years, Mangoceuticals' EBIAT (Quarter) stood at -$2.6 million in 2023, then grew by 24.12% to -$1.9 million in 2024, then crashed by 290.99% to -$7.6 million in 2025.
- Its EBIAT stands at -$7.6 million for Q3 2025, versus -$5.4 million for Q2 2025 and -$4.8 million for Q1 2025.